BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Tong YF, Lv J, Ying LY, Xu F, Qin B, Chen MT, Meng F, Tu MY, Yang NM, Li YM, Zhang JZ. Seven-day triple therapy is a better choice for Helicobacter pylori eradication in regions with low antibiotic resistance. World J Gastroenterol 2015; 21(46): 13073-13079 [PMID: 26672777 DOI: 10.3748/wjg.v21.i46.13073]
URL: https://www.wjgnet.com/1007-9327/full/v21/i46/13073.htm
Number Citing Articles
1
Peter H. Katelaris, Anthea L. Katelaris. A prospective evaluation of levofloxacin‐based triple therapy for refractory Helicobacter pylori infection in AustraliaInternal Medicine Journal 2017; 47(7): 761 doi: 10.1111/imj.13432
2
Shivaram Prasad Singh, Vineet Ahuja, Uday C. Ghoshal, Govind Makharia, Usha Dutta, Showkat Ali Zargar, Jayanthi Venkataraman, Amit Kumar Dutta, Asish K Mukhopadhyay, Ayaskanta Singh, Babu Ram Thapa, Kim Vaiphei, Malathi Sathiyasekaran, Manoj K. Sahu, Niranjan Rout, Philip Abraham, Prakash Chandra Dalai, Pravin Rathi, Saroj K. Sinha, Shobna Bhatia, Susama Patra, Ujjala Ghoshal, Ujjal Poddar, Venigalla Pratap Mouli, Vikram Kate. Management of Helicobacter pylori infection: The Bhubaneswar Consensus Report of the Indian Society of GastroenterologyIndian Journal of Gastroenterology 2021; 40(4): 420 doi: 10.1007/s12664-021-01186-4
3
Soichiro Sue, Marina Ogushi, Isao Arima, Hirofumi Kuwashima, Satoshi Nakao, Makoto Naito, Kazuo Komatsu, Hiroaki Kaneko, Toshihide Tamura, Tomohiko Sasaki, Masaaki Kondo, Wataru Shibata, Shin Maeda. Vonoprazan‐ vs proton‐pump inhibitor‐based first‐line 7‐day triple therapy for clarithromycin‐susceptible Helicobacter pylori: A multicenter, prospective, randomized trialHelicobacter 2018; 23(2) doi: 10.1111/hel.12456
4
Anthony O'Connor, Wolfgang Fischbach, Javier P. Gisbert, Colm O'Morain. Treatment of Helicobacter pylori infection 2016Helicobacter 2016; 21(S1): 55 doi: 10.1111/hel.12342
5
Jian‐Wei Yun, Cui Wang, Yi Yu, Hui‐Mei Xu, Ling‐Zhu Gou, Xiao‐Li Li, Gui‐Rong Yi, Yi‐Ming Lin, Ti‐Yun Han, De‐Kui Zhang. High‐dose amoxicillin‐proton pump inhibitor dual therapy as first‐line treatment for Helicobacter pylori infection in Northwest China: A prospective, randomised controlled trialBritish Journal of Clinical Pharmacology 2023; 89(1): 232 doi: 10.1111/bcp.15488
6
Jiaoe Chen, Liping Ye, Liangmin Jin, Xuehua Xu, Peisong Xu, Xianjun Wang, Hongzhang Li. Application of next-generation sequencing to characterize novel mutations in clarithromycin-susceptible Helicobacter pylori strains with A2143G of 23S rRNA geneAnnals of Clinical Microbiology and Antimicrobials 2018; 17(1) doi: 10.1186/s12941-018-0259-8
7
Jie Pan, Zhengchao Shi, Dingsai Lin, Ningmin Yang, Fei Meng, Lang Lin, Zhencheng Jin, Qingjie Zhou, Jiansheng Wu, Jianzhong Zhang, Youming Li. Is tailored therapy based on antibiotic susceptibility effective ? a multicenter, open-label, randomized trialFrontiers of Medicine 2020; 14(1): 43 doi: 10.1007/s11684-019-0706-8
8
Yunzhi Zou, Xing Qian, Xiaoqun Liu, YanPing Song, Conghua Song, Shuang Wu, Ying An, Rui Yuan, Youhua Wang, Yong Xie. The effect of antibiotic resistance on Helicobacter pylori eradication efficacy: A systematic review and meta‐analysisHelicobacter 2020; 25(4) doi: 10.1111/hel.12714
9
Yao Chen, Qingyi Liu, Fulian Hu, Jizheng Ma. Identifying the best regimen for primary eradication of Helicobacter pylori: analysis of 240 casesMicrobiologyOpen 2020; 9(11) doi: 10.1002/mbo3.1120
10
Huo-Ye Gan, Tie-Li Peng, You-Ming Huang, Kai-Hua Su, Lin-Li Zhao, Li-Ya Yao, Rong-Jiao Yang. Efficacy of two different dosages of levofloxacin in curing Helicobacter pylori infection: A Prospective, Single-Center, randomized clinical trialScientific Reports 2018; 8(1) doi: 10.1038/s41598-018-27482-2
11
Alessia Savoldi, Elena Carrara, David Y. Graham, Michela Conti, Evelina Tacconelli. Prevalence of Antibiotic Resistance in Helicobacter pylori: A Systematic Review and Meta-analysis in World Health Organization RegionsGastroenterology 2018; 155(5): 1372 doi: 10.1053/j.gastro.2018.07.007
12
Reka Borka Balas, Lorena Elena Meliț, Cristina Oana Mărginean. Current Worldwide Trends in Pediatric Helicobacter pylori Antimicrobial ResistanceChildren 2023; 10(2): 403 doi: 10.3390/children10020403
13
Salma Burayzat, Mohammad Al-Tamimi, Mohammad Barqawi, Mustafa Sabri Massadi, Jumanah Abu-Raideh, Hadeel Albalawi, Ashraf I. Khasawneh, Nisreen Himsawi, Maha Barber. Antimicrobial Resistance Molecular Mechanisms of Helicobacter pylori in Jordanian Children: A Cross-Sectional Observational StudyAntibiotics 2023; 12(3): 618 doi: 10.3390/antibiotics12030618